Results 121 to 130 of about 1,312,400 (160)

Biomarker-Specific Survival and Medication Cost for Patients With Non-Small Cell Lung Cancer.

JAMA Netw Open
Tan J, Yang SC, Dinan MA, Chiang AC, Gross CP, Wang SY.   +5 more
europepmc   +1 more source

Advancements in Biomarkers for Early Detection and Risk Stratification of Cardiovascular Diseases-A Literature Review. [PDF]

Health Sci Rep
Nazir A, Nazir A, Afzaal U, Aman S, Sadiq SUR, Akah OZ, Jamal MSW, Hassan SZ.   +7 more
europepmc   +1 more source

Improving Prediction of Postoperative Atrial Fibrillation After Cardiac Surgery Using Multiple Pathophysiological Biomarkers: A Prospective Double-Centre Study. [PDF]

J Clin Med
Noordzij PG, Thio MSY, Reniers T, Dijkstra I, Mondelli G, Langelaan M, Ruven HJT, Rettig TCD.   +7 more
europepmc   +1 more source

A novel mechanosensitive stress test in individuals following anterior cruciate ligament reconstruction: A pilot study. [PDF]

Osteoarthr Cartil Open
Jayabalan P, Darcy R, Darbhe V, Neuville Z, Tjong V, Hargrove L, Welty L, Schnitzer T.   +7 more
europepmc   +1 more source

Role of Biomarkers in Diagnosing Disease, Assessing the Severity and Progression of Disease, and Evaluating the Efficacy of Therapies. [PDF]

J Inherit Metab Dis
Schiffmann R.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Nature Medicine, 2019
T. Powles, M. Kockx, A. Rodríguez-Vida, I. Durán, S. Crabb, M. S. van der Heijden, B. Szabados, A. Pous, G. Gravis, U. A. Herranz, A. Protheroe, A. Ravaud, D. Maillet, M. Mendez, C. Suarez, M. Linch, Aaron Prendergast, Pieter-Jan van Dam, Diana Stanoeva, S. Daelemans, S. Mariathasan, Joy S. Tea, K. Mousa, R. Banchereau, D. Castellano   +24 more
semanticscholar   +3 more sources

Biomarkers: to be or not to be

Annals of the Rheumatic Diseases, 2020
We read with great interest the article by van den Hoogen et al 1 describing galectin-9 (Gal-9) as a novel, easy-to-measure biomarker for the interferon (IFN) signature in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). We support the views expressed by the authors that IFN signature is an important biomarker in disease activity
Lars Rönnblom, Sule Yavuz
openaire   +3 more sources

Biomarkers

2015
Biomarkers are key tools and can provide crucial information on the complex cascade of events and molecular mechanisms underlying traumatic brain injury (TBI) pathophysiology. Obtaining a profile of distinct classes of biomarkers reflecting core pathologic mechanisms could enable us to identify and characterize the initial injury and the secondary ...
MONDELLO, STEFANIA, Hayes, Ronald L.
openaire   +3 more sources

Biomarkers of tolerance

Current Opinion in Organ Transplantation, 2013
As the induction and maintenance of donor-specific tolerance is a central aim in solid organ transplantation, it is essential that clinicians are able to identify and monitor tolerance accurately and reliably. This review highlights recent advances in defining sets of biomarkers in noninvasive samples that may guide minimization and withdrawal of ...
Gökmen, Refik, Hernandez Fuentes, Maria
openaire   +3 more sources

Biomarkers in aggression

2019
Aggressive behavior exerts an enormous impact on society remaining among the main causes of worldwide premature death. Effective primary interventions, relying on predictive models of aggression that show adequate sensitivity and specificity are currently lacking.
Vassilios Fanos, Mirko Manchia, Mirko Manchia, Martina Pinna, Bernardo Carpiniello, Eileen M. Denovan-Wright, Stefano Comai, Stefano Comai, Federica Pinna   +8 more
openaire   +3 more sources